Pediatr. Res. 2020 Feb 01
Dose-escalation trial of budesonide in surfactant for prevention of bronchopulmonary dysplasia in extremely low gestational age high-risk newborns (SASSIE).
McEvoy CT, Ballard PL, Ward RM, Rower JE, Wadhawan R, Hudak ML, Weitkamp JH, Harris J, Asselin J, Chapin C, Ballard RA
Initial trials of lung-targeted budesonide (0.25?mg/kg) in surfactant to prevent bronchopulmonary dysplasia (BPD) in premature infants have shown bene ...
Read More
Source: PubMed
Trials
Impact of an integrated nutrition, health, water sanitation and hygiene, psychosocial care and support intervention package delivered during the pre- and peri-conception period and/or during pregnancy and early childhood on linear growth of infants in the first two years of life, birth outcomes and nutritional status of mothers: study protocol of a factorial, individually randomized controlled trial in India.
Taneja S, Chowdhury R, Dhabhai N, Mazumder S, Upadhyay RP, Sharma S, Dewan R, Mittal P, Chellani H, Bahl R, Bhan MK, Bhandari N
The period from conception to two years of life denotes a critical window of opportunity for promoting optimal growth and development of children. Poo ...
Read More
Source: PubMed
Trials
Operationalising kangaroo Mother care before stabilisation amongst low birth Weight Neonates in Africa (OMWaNA): protocol for a randomised controlled trial to examine mortality impact in Uganda.
Medvedev MM, Tumukunde V, Mambule I, Tann CJ, Waiswa P, Canter RR, Hansen CH, Ekirapa-Kiracho E, Katumba K, Pitt C, Greco G, Brotherton H, Elbourne D, Seeley J, Nyirenda M, Allen E, Lawn JE
There are 2.5 million neonatal deaths each year; the majority occur within 48?h of birth, before stabilisation. Evidence from 11 trials shows that kan ...
Read More
Source: PubMed
Econ Hum Biol
Newborn health and the business cycle: The role of birth order.
Aparicio A, González L, Vall Castelló J
We use 35?years of administrative data to document how newborn health varies with the business cycle in Spain. In panel regressions that include provi ...
Read More
Source: PubMed
J. Hazard. Mater.
Sex difference in bronchopulmonary dysplasia of offspring in response to maternal PM2.5 exposure.
Yue H, Ji X, Ku T, Li G, Sang N
The adverse effects of fine particulate matters (PM2.5) on respiratory diseases start in utero. In order to investigate whether maternal PM2.5 exposur ...
Read More
Source: PubMed
Pediatr. Res. 2020 Feb 01
Dose-escalation trial of budesonide in surfactant for prevention of bronchopulmonary dysplasia in extremely low gestational age high-risk newborns (SASSIE).
McEvoy CT, Ballard PL, Ward RM, Rower JE, Wadhawan R, Hudak ML, Weitkamp JH, Harris J, Asselin J, Chapin C, Ballard RA
Initial trials of lung-targeted budesonide (0.25?mg/kg) in surfactant to prevent bronchopulmonary dysplasia (BPD) in premature infants have shown bene ...
Read More
Source: PubMed
Trials
Impact of an integrated nutrition, health, water sanitation and hygiene, psychosocial care and support intervention package delivered during the pre- and peri-conception period and/or during pregnancy and early childhood on linear growth of infants in the first two years of life, birth outcomes and nutritional status of mothers: study protocol of a factorial, individually randomized controlled trial in India.
Taneja S, Chowdhury R, Dhabhai N, Mazumder S, Upadhyay RP, Sharma S, Dewan R, Mittal P, Chellani H, Bahl R, Bhan MK, Bhandari N
The period from conception to two years of life denotes a critical window of opportunity for promoting optimal growth and development of children. Poo ...
Read More
Source: PubMed
Trials
Operationalising kangaroo Mother care before stabilisation amongst low birth Weight Neonates in Africa (OMWaNA): protocol for a randomised controlled trial to examine mortality impact in Uganda.
Medvedev MM, Tumukunde V, Mambule I, Tann CJ, Waiswa P, Canter RR, Hansen CH, Ekirapa-Kiracho E, Katumba K, Pitt C, Greco G, Brotherton H, Elbourne D, Seeley J, Nyirenda M, Allen E, Lawn JE
There are 2.5 million neonatal deaths each year; the majority occur within 48?h of birth, before stabilisation. Evidence from 11 trials shows that kan ...
Read More
Source: PubMed
Econ Hum Biol
Newborn health and the business cycle: The role of birth order.
Aparicio A, González L, Vall Castelló J
We use 35?years of administrative data to document how newborn health varies with the business cycle in Spain. In panel regressions that include provi ...
Read More
Source: PubMed
J. Hazard. Mater.
Sex difference in bronchopulmonary dysplasia of offspring in response to maternal PM2.5 exposure.
Yue H, Ji X, Ku T, Li G, Sang N
The adverse effects of fine particulate matters (PM2.5) on respiratory diseases start in utero. In order to investigate whether maternal PM2.5 exposur ...
Read More
Source: PubMed
Pediatr. Res. 2020 Feb 01
Dose-escalation trial of budesonide in surfactant for prevention of bronchopulmonary dysplasia in extremely low gestational age high-risk newborns (SASSIE).
McEvoy CT, Ballard PL, Ward RM, Rower JE, Wadhawan R, Hudak ML, Weitkamp JH, Harris J, Asselin J, Chapin C, Ballard RA
Initial trials of lung-targeted budesonide (0.25?mg/kg) in surfactant to prevent bronchopulmonary dysplasia (BPD) in premature infants have shown bene ...
Read More
Source: PubMed
Trials
Impact of an integrated nutrition, health, water sanitation and hygiene, psychosocial care and support intervention package delivered during the pre- and peri-conception period and/or during pregnancy and early childhood on linear growth of infants in the first two years of life, birth outcomes and nutritional status of mothers: study protocol of a factorial, individually randomized controlled trial in India.
Taneja S, Chowdhury R, Dhabhai N, Mazumder S, Upadhyay RP, Sharma S, Dewan R, Mittal P, Chellani H, Bahl R, Bhan MK, Bhandari N
The period from conception to two years of life denotes a critical window of opportunity for promoting optimal growth and development of children. Poo ...
Read More
Source: PubMed
Trials
Operationalising kangaroo Mother care before stabilisation amongst low birth Weight Neonates in Africa (OMWaNA): protocol for a randomised controlled trial to examine mortality impact in Uganda.
Medvedev MM, Tumukunde V, Mambule I, Tann CJ, Waiswa P, Canter RR, Hansen CH, Ekirapa-Kiracho E, Katumba K, Pitt C, Greco G, Brotherton H, Elbourne D, Seeley J, Nyirenda M, Allen E, Lawn JE
There are 2.5 million neonatal deaths each year; the majority occur within 48?h of birth, before stabilisation. Evidence from 11 trials shows that kan ...
Read More
Source: PubMed
Econ Hum Biol
Newborn health and the business cycle: The role of birth order.
Aparicio A, González L, Vall Castelló J
We use 35?years of administrative data to document how newborn health varies with the business cycle in Spain. In panel regressions that include provi ...
Read More
Source: PubMed
J. Hazard. Mater.
Sex difference in bronchopulmonary dysplasia of offspring in response to maternal PM2.5 exposure.
Yue H, Ji X, Ku T, Li G, Sang N
The adverse effects of fine particulate matters (PM2.5) on respiratory diseases start in utero. In order to investigate whether maternal PM2.5 exposur ...
Read More
Source: PubMed
Pediatr. Res. 2020 Feb 01
Dose-escalation trial of budesonide in surfactant for prevention of bronchopulmonary dysplasia in extremely low gestational age high-risk newborns (SASSIE).
McEvoy CT, Ballard PL, Ward RM, Rower JE, Wadhawan R, Hudak ML, Weitkamp JH, Harris J, Asselin J, Chapin C, Ballard RA
Initial trials of lung-targeted budesonide (0.25?mg/kg) in surfactant to prevent bronchopulmonary dysplasia (BPD) in premature infants have shown bene ...
Read More
Source: PubMed
Trials
Impact of an integrated nutrition, health, water sanitation and hygiene, psychosocial care and support intervention package delivered during the pre- and peri-conception period and/or during pregnancy and early childhood on linear growth of infants in the first two years of life, birth outcomes and nutritional status of mothers: study protocol of a factorial, individually randomized controlled trial in India.
Taneja S, Chowdhury R, Dhabhai N, Mazumder S, Upadhyay RP, Sharma S, Dewan R, Mittal P, Chellani H, Bahl R, Bhan MK, Bhandari N
The period from conception to two years of life denotes a critical window of opportunity for promoting optimal growth and development of children. Poo ...
Read More
Source: PubMed
Trials
Operationalising kangaroo Mother care before stabilisation amongst low birth Weight Neonates in Africa (OMWaNA): protocol for a randomised controlled trial to examine mortality impact in Uganda.
Medvedev MM, Tumukunde V, Mambule I, Tann CJ, Waiswa P, Canter RR, Hansen CH, Ekirapa-Kiracho E, Katumba K, Pitt C, Greco G, Brotherton H, Elbourne D, Seeley J, Nyirenda M, Allen E, Lawn JE
There are 2.5 million neonatal deaths each year; the majority occur within 48?h of birth, before stabilisation. Evidence from 11 trials shows that kan ...
Read More
Source: PubMed
Econ Hum Biol
Newborn health and the business cycle: The role of birth order.
Aparicio A, González L, Vall Castelló J
We use 35?years of administrative data to document how newborn health varies with the business cycle in Spain. In panel regressions that include provi ...
Read More
Source: PubMed
J. Hazard. Mater.
Sex difference in bronchopulmonary dysplasia of offspring in response to maternal PM2.5 exposure.
Yue H, Ji X, Ku T, Li G, Sang N
The adverse effects of fine particulate matters (PM2.5) on respiratory diseases start in utero. In order to investigate whether maternal PM2.5 exposur ...
Read More
Source: PubMed
Pediatr. Res. 2020 Feb 01
Dose-escalation trial of budesonide in surfactant for prevention of bronchopulmonary dysplasia in extremely low gestational age high-risk newborns (SASSIE).
McEvoy CT, Ballard PL, Ward RM, Rower JE, Wadhawan R, Hudak ML, Weitkamp JH, Harris J, Asselin J, Chapin C, Ballard RA
Initial trials of lung-targeted budesonide (0.25?mg/kg) in surfactant to prevent bronchopulmonary dysplasia (BPD) in premature infants have shown bene ...
Read More
Source: PubMed
Trials
Impact of an integrated nutrition, health, water sanitation and hygiene, psychosocial care and support intervention package delivered during the pre- and peri-conception period and/or during pregnancy and early childhood on linear growth of infants in the first two years of life, birth outcomes and nutritional status of mothers: study protocol of a factorial, individually randomized controlled trial in India.
Taneja S, Chowdhury R, Dhabhai N, Mazumder S, Upadhyay RP, Sharma S, Dewan R, Mittal P, Chellani H, Bahl R, Bhan MK, Bhandari N
The period from conception to two years of life denotes a critical window of opportunity for promoting optimal growth and development of children. Poo ...
Read More
Source: PubMed
Trials
Operationalising kangaroo Mother care before stabilisation amongst low birth Weight Neonates in Africa (OMWaNA): protocol for a randomised controlled trial to examine mortality impact in Uganda.
Medvedev MM, Tumukunde V, Mambule I, Tann CJ, Waiswa P, Canter RR, Hansen CH, Ekirapa-Kiracho E, Katumba K, Pitt C, Greco G, Brotherton H, Elbourne D, Seeley J, Nyirenda M, Allen E, Lawn JE
There are 2.5 million neonatal deaths each year; the majority occur within 48?h of birth, before stabilisation. Evidence from 11 trials shows that kan ...
Read More
Source: PubMed
Econ Hum Biol
Newborn health and the business cycle: The role of birth order.
Aparicio A, González L, Vall Castelló J
We use 35?years of administrative data to document how newborn health varies with the business cycle in Spain. In panel regressions that include provi ...
Read More
Source: PubMed
J. Hazard. Mater.
Sex difference in bronchopulmonary dysplasia of offspring in response to maternal PM2.5 exposure.
Yue H, Ji X, Ku T, Li G, Sang N
The adverse effects of fine particulate matters (PM2.5) on respiratory diseases start in utero. In order to investigate whether maternal PM2.5 exposur ...
Read More
Source: PubMed
Pediatr. Res. 2020 Feb 01
Dose-escalation trial of budesonide in surfactant for prevention of bronchopulmonary dysplasia in extremely low gestational age high-risk newborns (SASSIE).
McEvoy CT, Ballard PL, Ward RM, Rower JE, Wadhawan R, Hudak ML, Weitkamp JH, Harris J, Asselin J, Chapin C, Ballard RA
Initial trials of lung-targeted budesonide (0.25?mg/kg) in surfactant to prevent bronchopulmonary dysplasia (BPD) in premature infants have shown bene ...
Read More
Source: PubMed
Trials
Impact of an integrated nutrition, health, water sanitation and hygiene, psychosocial care and support intervention package delivered during the pre- and peri-conception period and/or during pregnancy and early childhood on linear growth of infants in the first two years of life, birth outcomes and nutritional status of mothers: study protocol of a factorial, individually randomized controlled trial in India.
Taneja S, Chowdhury R, Dhabhai N, Mazumder S, Upadhyay RP, Sharma S, Dewan R, Mittal P, Chellani H, Bahl R, Bhan MK, Bhandari N
The period from conception to two years of life denotes a critical window of opportunity for promoting optimal growth and development of children. Poo ...
Read More
Source: PubMed
Trials
Operationalising kangaroo Mother care before stabilisation amongst low birth Weight Neonates in Africa (OMWaNA): protocol for a randomised controlled trial to examine mortality impact in Uganda.
Medvedev MM, Tumukunde V, Mambule I, Tann CJ, Waiswa P, Canter RR, Hansen CH, Ekirapa-Kiracho E, Katumba K, Pitt C, Greco G, Brotherton H, Elbourne D, Seeley J, Nyirenda M, Allen E, Lawn JE
There are 2.5 million neonatal deaths each year; the majority occur within 48?h of birth, before stabilisation. Evidence from 11 trials shows that kan ...
Read More
Source: PubMed
Econ Hum Biol
Newborn health and the business cycle: The role of birth order.
Aparicio A, González L, Vall Castelló J
We use 35?years of administrative data to document how newborn health varies with the business cycle in Spain. In panel regressions that include provi ...
Read More
Source: PubMed
J. Hazard. Mater.
Sex difference in bronchopulmonary dysplasia of offspring in response to maternal PM2.5 exposure.
Yue H, Ji X, Ku T, Li G, Sang N
The adverse effects of fine particulate matters (PM2.5) on respiratory diseases start in utero. In order to investigate whether maternal PM2.5 exposur ...
Read More
Source: PubMed
